The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

ellaOne 30 mg tablet

Laboratoire HRA PharmaEU/1/09/522/001

Main Information

Trade NameellaOne 30 mg tablet
Active SubstancesULIPRISTAL (INN)
Dosage FormTablet
Licence HolderLaboratoire HRA Pharma
Licence NumberEU/1/09/522/001

Group Information

ATC CodeG03AD Emergency contraceptives
G03AD02 ulipristal


License statusAuthorised
Licence Issued15/05/2009
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0154-033-014
Interchangeable List DocumentPDF of Interchangeable List
« Back